Your browser doesn't support javascript.
loading
Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Saito, Shoji; Nakazawa, Yozo; Sueki, Akane; Matsuda, Kazuyuki; Tanaka, Miyuki; Yanagisawa, Ryu; Maeda, Yasuhiro; Sato, Yuko; Okabe, Seiichi; Inukai, Takeshi; Sugita, Kanji; Wilson, Matthew H; Rooney, Cliona M; Koike, Kenichi.
Afiliación
  • Saito S; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakazawa Y; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. Electronic address: yxnakaza@shinshu-u.ac.jp.
  • Sueki A; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
  • Matsuda K; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
  • Tanaka M; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
  • Yanagisawa R; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
  • Maeda Y; Department of Hematology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.
  • Sato Y; Japanese Red Cross College of Nursing, Tokyo, Japan.
  • Okabe S; First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Wilson MH; Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Rooney CM; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.
  • Koike K; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Cytotherapy ; 16(9): 1257-69, 2014 Sep.
Article en En | MEDLINE | ID: mdl-25108652

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia Mielógena Crónica BCR-ABL Positiva / Inmunoterapia Adoptiva / Vacunas contra el Cáncer / Inhibidores de Proteínas Quinasas Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2014 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia Mielógena Crónica BCR-ABL Positiva / Inmunoterapia Adoptiva / Vacunas contra el Cáncer / Inhibidores de Proteínas Quinasas Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2014 Tipo del documento: Article País de afiliación: Japón